Загрузка...
1597. Risk Factors for Failure of Primary (Val)ganciclovir Prophylaxis Against Cytomegalovirus (CMV) Infection and Disease in Solid Organ Transplant (SOT) Recipients
BACKGROUND: Following solid-organ transplantation (SOT), the optimal dose of primary (val)ganciclovir (v(gcv)) prophylaxis against CMV infection is debated, and breakthrough infection and treatment-limiting side effects are frequently seen. Rates and risk factors for CMV prophylaxis breakthrough and...
Сохранить в:
| Опубликовано в: : | Open Forum Infect Dis |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6253855/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.1425 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|